{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T22:26:54Z","timestamp":1775687214086,"version":"3.50.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1177\/1933719115620498","type":"journal-article","created":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T01:18:15Z","timestamp":1450747095000},"page":"830-837","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Why are We Waiting to Start Large Scale Clinical Testing of Human Chorionic Gonadotropin for the Treatment of Preterm Births?"],"prefix":"10.1007","volume":"23","author":[{"given":"C. V.","family":"Rao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,30]]},"reference":[{"issue":"suppl 3","key":"23070830_CR1","first-page":"136","volume":"62","author":"JA Martin","year":"2013","unstructured":"Martin JAPreterm births-United States, 2006 and 2010; Centers for Disease Control and Prevention. MMWR Surveill Summ. 2013;62(suppl 3):136\u2013138.","journal-title":"MMWR Surveill Summ"},{"key":"23070830_CR2","unstructured":"Centers for Disease Control and Prevention. Preterm Births. Web site. http:\/\/www.cdc.gov\/reproductivehealth\/maternalinfanthealth\/pretermbirth.htm. Updated October 28, 2015. Accessed November 2015."},{"issue":"1","key":"23070830_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/1552-6909.12533","volume":"44","author":"B Baker","year":"2015","unstructured":"Baker B. Evidence-based practice to improve outcomes for late preterm infants. J Obstet Gynecol Neonatal Nurs. 2015;44(1):127\u2013134.","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"issue":"5","key":"23070830_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/jp.2015.19","volume":"35","author":"NL Maitre","year":"2015","unstructured":"Maitre NL, Ballard RA, Ellenberg JH, Greenberg JM, Hamvas A, Pryhuber GS. State-of- the-art. Respiratory consequences of prematurity: evolution of a diagnosis and development of a comphehensive approach. J Perinatol. 2015;35(5):1\u20139.","journal-title":"J Perinatol"},{"key":"23070830_CR5","doi-asserted-by":"crossref","unstructured":"Theplib A, Phupong V. Success rate of terbuline in inhibiting pre-term labor for 48 h. J Matern Fetal Neonatal Med. 2015:1\u20134.","DOI":"10.3109\/14767058.2015.1021671"},{"issue":"9090","key":"23070830_CR6","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/S0140-6736(05)63935-9","volume":"350","author":"P Bennett","year":"1997","unstructured":"Bennett P, Edwards V. Use of magnesium sulfate in obstetrics. Lancet. 1997;350(9090):1491.","journal-title":"Lancet"},{"key":"23070830_CR7","unstructured":"Lei ZM, Rao CV. Endocrinology of the trophoblast tissue. In: Becker K Principles and Practice of Endocrinology and Metbaolism, 3rd Edition. Philadelphia, PA: Lippincott Williams & Wilkins; 2001: 1096\u20131102."},{"issue":"6","key":"23070830_CR8","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1210\/endo.133.6.8243330","volume":"133","author":"P Licht","year":"1993","unstructured":"Licht P, Cao H, Lei ZM, Rao ChV, Merz WM. Novel self-regulation of human chorionic gonadotropin biosynthesis in term pregnancy human placenta. Endocrinology. 1993;133(6):3014\u20133025.","journal-title":"Endocrinology"},{"key":"23070830_CR9","first-page":"269","volume-title":"Chapter 8, Endocrinology of Pregnancy, In: Clinical Gynecologic Endocrinology and Infertility","author":"MC Fritz","year":"2011","unstructured":"Fritz MC, Speroff L. Chapter 8, Endocrinology of Pregnancy, In: Clinical Gynecologic Endocrinology and Infertility. 8th edition. Philadelphia, PA: Wolters Kluwer Health\/Lippincott Williams & Wilkins; 2011: 269\u2013330.","edition":"8th edition"},{"issue":"1","key":"23070830_CR10","doi-asserted-by":"publisher","first-page":"r13","DOI":"10.1016\/0303-7207(95)03565-O","volume":"111","author":"J Lin","year":"1995","unstructured":"Lin J, Lojun S, Lei ZM, Wu WX, Peiper SC, Rao ChV. Lymphocytes from pregnant women express human chorionic gonadotropin \/ luteinizing hormone receptor gene. Mol Cell Endocrinol. 1995;111(1):r13\u2013r17.","journal-title":"Mol Cell Endocrinol"},{"issue":"suppl 1","key":"23070830_CR11","first-page":"Abstr 46","volume":"6","author":"YM Zhang","year":"1999","unstructured":"Zhang YM, Lei ZM, Rao ChV. Functional importance of human monocyte luteinizing hormone and chorionic gonadotropin receptors. J Soc Gynecol Invest. 1999;6(suppl 1):Abstr 46.","journal-title":"J Soc Gynecol Invest"},{"issue":"1","key":"23070830_CR12","first-page":"1","volume":"19","author":"CV Rao","year":"2001","unstructured":"Rao CV. Nongonadal actions of LH and hCG in reproductive biology and medicine. Sem Reprod Med. 2001l;(Guest editor);19(1):1\u2013119.","journal-title":"Sem Reprod Med"},{"issue":"2","key":"23070830_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1034\/j.1600-0897.2003.00013.x","volume":"49","author":"YM Zhang","year":"2003","unstructured":"Zhang YM, Rao ChV, Lei ZM. Macrophages in human reproductive tissues contain luteinizing hormone\/chorionic gonadotropin receptors. Am J Reprod Immunol. 2003;49(2):93\u2013100.","journal-title":"Am J Reprod Immunol"},{"issue":"2","key":"23070830_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1034\/j.1600-0897.2003.00063.x","volume":"50","author":"T Yoshimura","year":"2003","unstructured":"Yoshimura T, Inaba M, Suguira K, et al. Analyses of dendritic cell subsets in pregnancy. Am J Reprod Immunol. 2003;50(2):137\u2013145.","journal-title":"Am J Reprod Immunol"},{"issue":"1-2","key":"23070830_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2006.07.007","volume":"269","author":"CV Rao","year":"2007","unstructured":"Rao CV, Lei ZM. The past, present and future of nongonadal LH\/hCG actions in reproductive biology and medicine. Mol Cell Endocrinol. 2007;269(1\u20132):2\u20138.","journal-title":"Mol Cell Endocrinol"},{"issue":"11","key":"23070830_CR16","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/molehr\/gap067","volume":"15","author":"N Rahman","year":"2009","unstructured":"Rahman N, Rao CV. Recent progress in luteinizing hormone\/human chorionic gonadotropin hormone research. Mol Human Reprod. 2009;15(11):703\u2013711.","journal-title":"Mol Human Reprod"},{"issue":"1","key":"23070830_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jri.2009.11.008","volume":"85","author":"M Tsampalas","year":"2010","unstructured":"Tsampalas M, Gridelet V, Berndt S, Foidart J-M, Geenen V, d\u2019Hauterive SP. Human chorionic gonadotropin: a hormone with immunological and angiogenic properties. J Reprod Immunol. 2010;85(1):93\u201398.","journal-title":"J Reprod Immunol"},{"issue":"6","key":"23070830_CR18","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1210\/endo.135.6.7988470","volume":"135","author":"G Ambrus","year":"1994","unstructured":"Ambrus G, Rao ChV. Novel regulation of pregnant human myometrial smooth muscle cell gap junctions by human chorionic gonadotropin. Endocrinology. 1994;135(6):2772\u20132779.","journal-title":"Endocrinology"},{"issue":"6","key":"23070830_CR19","first-page":"1582","volume":"79","author":"E Eta","year":"1994","unstructured":"Eta E, Ambrus G, Rao ChV. Direct regulation of human myometrial contractions by human chorionic gonadotropin. J Clin Endocrinol Metab. 1994;79(6):1582\u20131586.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"23070830_CR20","first-page":"704","volume":"108","author":"MM Slattery","year":"2001","unstructured":"Slattery MM, Brennan C, O\u2019Leary MJ, Morrison JJ. Human chorionic gonadotropin inhibition of pregnant human myometrial contractility. Brit J Obstet Gynaecol. 2001;108(7):704\u2013708.","journal-title":"Brit J Obstet Gynaecol"},{"key":"23070830_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-1-4612-1804-3_5","volume-title":"Endocrinology of Pregnancy","author":"ChV Rao","year":"1998","unstructured":"Rao ChV. Novel concepts in neuroendocrine regulation of reproductive tract functions. In: Bazer FW Endocrinology of Pregnancy. Totowa, NJ: The Human Press Inc, 1998: chapter 5:125\u2013144."},{"issue":"2","key":"23070830_CR22","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1210\/jcem-70-2-421","volume":"70","author":"E Reshef","year":"1990","unstructured":"Reshef E, Lei ZM, Rao ChV, Pridham DD, Chegini N, Luborsky JL. The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes and decidua. J Clin Endocrinol Metab. 1990;70(2):421\u2013430.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"23070830_CR23","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1095\/biolreprod49.6.1149","volume":"49","author":"JL K\u00f6rneyei","year":"1993","unstructured":"K\u00f6rneyei JL, Lei ZM, Rao ChV. Human myometrial smooth muscle cells are novel targets of direct regulation by human chorionic gonadotropin. Biol Reprod. 1993;49(6):1149\u20131157.","journal-title":"Biol Reprod"},{"issue":"1","key":"23070830_CR24","first-page":"307","volume":"79","author":"P Toth","year":"1994","unstructured":"Toth P, Li X, Rao ChV, et al. Expression of functional human chorionic gonadotropin\/human luteinizing hormone receptor gene in human uterine arteries. J Clin Endocrinol Metab. 1994;79(1): 307\u2013315.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"23070830_CR25","first-page":"907","volume":"79","author":"J Zuo","year":"1994","unstructured":"Zuo J, Lei ZM, Rao ChV. Human myometrial chorionic gonadotropin\/luteinizing hormone receptors in preterm and term deliveries. J Clin Endocrinol Metab. 1994;79(3):907\u2013911.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"23070830_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1055\/s-2001-13912","volume":"19","author":"J Kurtzman","year":"2001","unstructured":"Kurtzman J, Wilson H, Rao ChV. A proposed role for hCG in clinical obstetrics. Sem Reprod Med. 2001;19(1):63\u201368.","journal-title":"Sem Reprod Med"},{"issue":"11","key":"23070830_CR27","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1080\/14767050600921315","volume":"19","author":"C Ticconi","year":"2006","unstructured":"Ticconi C, Piccione E, Belmonte A, Rao Ch V. HCG - A new kid on the block in the prematurity prevention. J Matern Fetal Neonatal Med. 2006;19(11):687\u2013692","journal-title":"J Matern Fetal Neonatal Med"},{"key":"23070830_CR28","first-page":"s68","volume":"70","author":"MK Toppozada","year":"1998","unstructured":"Toppozada MK. Does hCG have a direct effect on the human myometrium? abstract. Fertil Steril 1998;70:s68.","journal-title":"Fertil Steril"},{"issue":"6","key":"23070830_CR29","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1210\/endo.132.6.8504751","volume":"132","author":"GN Europe-Finner","year":"1993","unstructured":"Europe-Finner GN, Phaneuf S, Watson SP, Lopez Bernal A. Identification and expression of G-proteins in human myometrium: upregulation of G alpha in pregnancy. Endocrinology. 1993();132(6):2484\u20132490.","journal-title":"Endocrinology"},{"issue":"2","key":"23070830_CR30","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1095\/biolreprod.105.040667","volume":"73","author":"DX Lin","year":"2005","unstructured":"Lin DX, Lei ZM, Rao ChV. Dependence of uterine cyclooxygenase2 expression on luteinizing hormone signaling. Biol Reprod. 2005;73(2):256\u2013260.","journal-title":"Biol Reprod"},{"issue":"8","key":"23070830_CR31","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jsgi.2005.09.002","volume":"12","author":"A Belmonte","year":"2005","unstructured":"Belmonte A, Ticconi C, Dolci S, et al. Regulation of phosphodiesterase 5 expression and activity in human pregnant and non-pregnant myometrial cells by human chorionic gonadotropin. J Soc Gynecol Invest. 2005;12(8):570\u2013577.","journal-title":"J Soc Gynecol Invest"},{"issue":"suppl a","key":"23070830_CR32","doi-asserted-by":"publisher","first-page":"s137","DOI":"10.1016\/j.placenta.2007.01.002","volume":"28","author":"C Ticconi","year":"2007","unstructured":"Ticconi C, Zicari A, Belmonte A, Realacci M, Rao ChV, Piccione E. Pregnancy \u2013 promoting actions of hCG in human myometrium and fetal membranes. Placenta. 2007;28(suppl a):s137\u2013s143.","journal-title":"Placenta"},{"issue":"1","key":"23070830_CR33","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ajog.2005.12.006","volume":"195","author":"C Mehats","year":"2006","unstructured":"Mehats C, Schmitz T, Breuiller-Fouche M, Leroy M-J, Cabrol D. Should phosphodiesterase 5 selective inhibitors be used for uterine relaxation? Am J Obstet Gynecol. 2006;195(1):184\u2013185.","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"23070830_CR34","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.1210\/jc.2003-030221","volume":"88","author":"HC Doheny","year":"2003","unstructured":"Doheny HC, Houlihan DD, Ravikumar N, Smith TJ, Morrison JJ. Human chorionic gonadotropin relaxation of human pregnant myometrium and activation of the BKca channel. J Clin Endocrinol Metab. 2003;88(9):4310\u20134315.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1-2","key":"23070830_CR35","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.mce.2004.09.011","volume":"234","author":"DX Lin","year":"2005","unstructured":"Lin DX, Lei ZM, Li X, Rao ChV. Targeted disruption of LH receptor gene revealed the importance of uterine LH signaling. Mol Cell Endocrinol. 2005;234(1\u20132):105\u2013116.","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"23070830_CR36","first-page":"894","volume":"79","author":"J Zuo","year":"1994","unstructured":"Zuo J, Lei ZM, Rao ChV, Pietrantoni M, Cook VD. Differential cyclooxygenase-1 and -2 gene expression in human myometria from preterm and term deliveries. J Clin Endocrinol Metab. 1994;79(3):894\u2013899.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"23070830_CR37","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1055\/s-2001-13911","volume":"19","author":"P Toth","year":"2001","unstructured":"Toth P. Clinical data supporting the importance of vascular LH\/hCG receptors of uterine blood vessels. Sem Reprod Med. 2001;19(1):55\u201361.","journal-title":"Sem Reprod Med"},{"issue":"7","key":"23070830_CR38","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1210\/jc.2002-021966","volume":"88","author":"PC Lin","year":"2003","unstructured":"Lin PC, Li X, Lei ZM, Rao ChV. Human cervix contains functional luteinizing hormone\/ human chorionic gonadotropin receptors. J Clin Endocrinol Metab. 2003;88(7):3409\u20133414.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"23070830_CR39","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/14767050600555808","volume":"19","author":"C Ticconi","year":"2006","unstructured":"Ticconi C, Belmonte A, Piccione E, Rao CV. Feto-placental communication system with myometrium in pregnancy and parturition: the role of hormones, neurohormones, inflammatory mediators, and locally active factors. J Mat Fetal Neonat Med. 2006;19(3):125\u2013133.","journal-title":"J Mat Fetal Neonat Med"},{"issue":"6","key":"23070830_CR40","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S1071-5576(02)00182-X","volume":"9","author":"S Bao","year":"2002","unstructured":"Bao S, Rai J, Schreiber J. Expression of nitric oxide synthase isoforms in human pregnant myometrium at term. J Soc Gynecol Invest. 2002;9(6):351\u2013356.","journal-title":"J Soc Gynecol Invest"},{"issue":"2","key":"23070830_CR41","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1530\/jrf.0.0920425","volume":"92","author":"B Flowers","year":"1991","unstructured":"Flowers B, Ziecik AJ, Caruolo EV. Effects of human chorionic gonadotropin on contractile activity of steroid-primed pig myometrium in vitro. J Reprod Fertil. 1991;92(2):425\u2013432.","journal-title":"J Reprod Fertil"},{"issue":"3","key":"23070830_CR42","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3109\/09513590.2010.488780","volume":"27","author":"S Angioni","year":"2011","unstructured":"Angioni S, Spedicato M, Rizzo A, et al. In vitro activity of human chorionic gonadotropin (hCG) on myometrium contractility. Gynecol Endocrinol. 2011;27(3);180\u2013184.","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"23070830_CR43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1530\/eje.0.1310103","volume":"131","author":"D Mukherjee","year":"1994","unstructured":"Mukherjee D, Manna PR, Bhattacharya S. Functional relevane of luteinizing hormone receptor in mouse uterus. Eur J Endocrinol. 1994;131(1):103\u2013108.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"23070830_CR44","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1530\/eje.0.1430799","volume":"143","author":"S Debnath","year":"2000","unstructured":"Debnath S, Mukherjee D, Bhattacharya SP. Stimulation of preg-nenolone metabolism and aromatase activity by luteinizing hormone in mouse uterus. Eur J Endocrinol. 2000;143(6):799\u2013807.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"23070830_CR45","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/biolreprod\/64.1.179","volume":"64","author":"M Zheng","year":"2001","unstructured":"Zheng M, Shi H, Segaloff DL, Van Voorhis J. Expression and localization of luteinizing hormone receptor in the female mouse reproductive tract. Biol Reprod. 2001;64(1):179\u2013187.","journal-title":"Biol Reprod"},{"issue":"2","key":"23070830_CR46","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0002-9378(96)70460-X","volume":"174","author":"N Kaga","year":"1996","unstructured":"Kaga N, Katsuki Y, Obata M, Shibutani Y. Repeated administration of low-dose lipopolysaccharide induces preterm delivery in mice: a model for human preterm parturition and for assessment of the therapeutic ability of drugs against preterm delivery. Am J Obstet Gynecol. 1996;174(2):754\u2013759.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"23070830_CR47","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.ajog.2006.06.013","volume":"195","author":"MA Elovitz","year":"2006","unstructured":"Elovitz MA, Mrinalini C. The use of progestational agents for pre-term birth: Lessons from a mouse model. Am J Obstet Gynecol. 2006;195(4):1004\u20131010.","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"23070830_CR48","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1177\/1933719110373148","volume":"17","author":"MW Kemp","year":"2010","unstructured":"Kemp MW, Saito M, Newnham JP, Nitsos I, Okamura K, Kallapur SG. Preterm birth, infection, and inflammation advances from the study of animal models. Reprod Sci. 2010;17(7):619\u2013628.","journal-title":"Reprod Sci"},{"issue":"4","key":"23070830_CR49","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/gm438","volume":"5","author":"KY Bezold","year":"2013","unstructured":"Bezold KY, Karjalainen MK, Hallman M, Teramo K, Muglia LJ. The genomics of preterm birth: from animal models to human studies. Genome Med. 2013;5(4):34.","journal-title":"Genome Med"},{"issue":"4","key":"23070830_CR50","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0002-9378(99)70313-3","volume":"181","author":"JT Kurtzman","year":"1999","unstructured":"Kurtzman JT, Spinnato JT, Goldsmith LJ, et al. Human chorionic gonadotropin exhibits potent inhibition of preterm delivery in a small animal model. Am J Obstet Gynecol. 1999;181(4):853\u2013857.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"23070830_CR51","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1530\/acta.0.0900696","volume":"90","author":"ChV Rao","year":"1979","unstructured":"Rao ChV. Differential properties of human chorionic gonadotropin and human luteinizing hormone binding to plasma membranes of bovine corpora lutea. Acta Endocrinol. 1979;90(4):696\u2013710.","journal-title":"Acta Endocrinol"},{"key":"23070830_CR52","first-page":"s201","volume":"182","author":"J Kurtzman","year":"2000","unstructured":"Kurtzman J, Jones E, Goldsmith LJ, et al. Inhibition of preterm delivery by human chorionic gonadotropin is associated with down-regulation of myometrial gap junctions. Am J Obstet Gynecol. 2000;182:s201.","journal-title":"Am J Obstet Gynecol"},{"issue":"4 suppl 1","key":"23070830_CR53","first-page":"s61","volume":"95","author":"AFM Ali","year":"2000","unstructured":"Ali AFM, Fateen B, Ezzet A, Badawy H, Ramadan A, El-tobge A. Treatment of preterm labor with human chorionic gonadotropin: a new modality. Am J Obstet Gynecol. 2000;95(4 suppl 1):s61.","journal-title":"Am J Obstet Gynecol"},{"issue":"suppl. a","key":"23070830_CR54","doi-asserted-by":"publisher","first-page":"s60","DOI":"10.1053\/plac.2002.0947","volume":"24","author":"NG Than","year":"2003","unstructured":"Than NG, Itakura A, Rao CV, et al. Clinical applications of pregnancy-related proteins \u2013 a workshop report. Placenta. 2003; 24(suppl. a):s60\u2013s64.","journal-title":"Placenta"},{"issue":"3","key":"23070830_CR55","first-page":"41","volume":"5","author":"N Lorzadeh","year":"2004","unstructured":"Lorzadeh N, Dehnoori A, Momennasab M. Human chorionic gonadotropin (hCG) versus magnesium sulfate to arrest preterm. Yafteh. 2004;5(3):41\u201346.","journal-title":"Yafteh"},{"issue":"3","key":"23070830_CR56","first-page":"134","volume":"9","author":"N Sakhavar","year":"2008","unstructured":"Sakhavar N, Mirteimoori M, Teimoori B. Magnesium sulfate versus hCG (Human Chorionic Gonadotropin) in suppression of pre-term labor. Shiraz E-Med J. 2008;9(3):134\u2013140.","journal-title":"Shiraz E-Med J"},{"key":"23070830_CR57","first-page":"1","volume":"65","author":"VU Rani","year":"2012","unstructured":"Rani VU, Reddy AM, Singh A, Malathi P. Role of hCG in preventing preterm labour in comparison with vaginal progesterone. Indian Pract. 2012;65:1\u20136.","journal-title":"Indian Pract"},{"issue":"4","key":"23070830_CR58","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ajog.2015.03.031","volume":"213","author":"A Suhag","year":"2015","unstructured":"Suhag A, Saccone G, Berghella V. Vaginal progesterone for maintenance tocolysis: a systematic review and meta-analysis of randomized trials. Am J Obstet Gynecol. 2015;213(4):479\u2013487.","journal-title":"Am J Obstet Gynecol"},{"issue":"24","key":"23070830_CR59","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1056\/NEJMoa035140","volume":"348","author":"PJ Meis","year":"2003","unstructured":"Meis PJ, Klebanoff M, Thorn E, et al. Prevention of recurrent pre-term delivery by 17 alpha-hydroxyprogesterone caproate. New Engl J Med. 2003;348(24):2379\u20132385.","journal-title":"New Engl J Med"},{"issue":"3","key":"23070830_CR60","doi-asserted-by":"publisher","first-page":"206e1","DOI":"10.1016\/j.ajog.2011.12.026","volume":"206","author":"P Rozenberg","year":"2012","unstructured":"Rozenberg P, Chauveaud A, Deruelle P, et al. Prevention of pre-term delivery after successful tocolysis in preterm labor by 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial. Am J Obstet Gynecol. 2012;206(3):206e1\u2013206e9","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"23070830_CR61","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1067\/mob.2003.41","volume":"188","author":"EB da Fonseca","year":"2003","unstructured":"da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: A randomized placebo-controlled double blind study. Am J Obstet Gynecol. 2003;188(2):419\u2013424.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"23070830_CR62","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/1471-0528.13061","volume":"122","author":"B Martinez de Tejada","year":"2015","unstructured":"Martinez de Tejada B, Karolinski A, Ocampo MC, et al. Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomized doubled-blind placebo-controlled trial. Brit J Obstet Gynecol. 2015;122(1):80\u201391.","journal-title":"Brit J Obstet Gynecol"},{"issue":"2","key":"23070830_CR63","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1471-0528.1990.tb01740.x","volume":"97","author":"MJ Keirse","year":"1990","unstructured":"Keirse MJ. Progestogen administration in pregnancy may prevent preterm delivery. Br J Obstet Gynaecol. 1990;97(2):149\u2013154.","journal-title":"Br J Obstet Gynaecol"},{"issue":"11","key":"23070830_CR64","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1177\/1933719109340926","volume":"16","author":"L Anderson","year":"2009","unstructured":"Anderson L, Martin W, Higgins C, Nelson SM, Norman JE. The effect of progesterone on myometrial contractility, potassium channels, and tocolytic efficacy. Reprod Sci. 2009;16(11):1052\u20131061.","journal-title":"Reprod Sci"},{"issue":"3","key":"23070830_CR65","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.semcdb.2007.05.003","volume":"18","author":"S Mesiano","year":"2007","unstructured":"Mesiano S, Welsh TN. Steroid hormone control of myometrial contractility and parturition. Semin Cell Dev Biol. 2007;18(3):321\u2013331.","journal-title":"Semin Cell Dev Biol"},{"issue":"9","key":"23070830_CR66","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1055\/s-0032-1316444","volume":"29","author":"JM O\u2019Brien","year":"2012","unstructured":"O\u2019Brien JM. The safety of preogesterone and 17-hydroxyprogesterone caproate administration for the prevention of preterm birth: an evidence-based assessment. Am J Perinatol. 2012;29(9):665\u2013672.","journal-title":"Am J Perinatol"},{"issue":"5","key":"23070830_CR67","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2165\/11208140-000000000-00000","volume":"13","author":"ED Deeks","year":"2011","unstructured":"Deeks ED.17 \u03b1-Hydroxyprogesterone caproate (Makena) in the prevention of preterm birth. Paediatr Drugs. 2011;13(5):337\u2013345.","journal-title":"Paediatr Drugs"},{"issue":"3","key":"23070830_CR68","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s40261-013-0060-6","volume":"33","author":"M Hines","year":"2013","unstructured":"Hines M, Lyseng-Williamson KA, Deeks ED. 17 \u03b1-hydroxyprogesterone caproate (Makena), A guide to its use in the prevention of preterm births. Clin Drug Invest. 2013;33(3):223\u2013227.","journal-title":"Clin Drug Invest"},{"issue":"1","key":"23070830_CR69","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.reprotox.2011.10.017","volume":"33","author":"P Merlob","year":"2012","unstructured":"Merlob P, Stahl B, Klinger G. 17\u03b1 Hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth. Reprod Toxicol. 2012;33(1):15\u201319.","journal-title":"Reprod Toxicol"},{"issue":"2","key":"23070830_CR70","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/14767050601178758","volume":"20","author":"MS Christian","year":"2007","unstructured":"Christian MS, Brent RL, Calda P. Embryo-fetal toxicity signals for 17 \u03b1-hydroxyprogesterone caproate in high-risk pregnancies: a review of the non-clinical literature for embryo-fetal toxicity with progestins. J Mat Fetal Neonat Med. 2007;20(2):89\u2013112.","journal-title":"J Mat Fetal Neonat Med"},{"issue":"9","key":"23070830_CR71","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.2337\/dc07-0564","volume":"30","author":"A Rebarber","year":"2007","unstructured":"Rebarber A, Istwan NB, Russo-Stieglitz K, et al. Increased incidence of gestational diabetes in women receiving prophylactic 17 \u03b1-hydroxyprogesterone caproate for prevention of recurrent preterm delivery. Diabetes Care. 2007;30(9):2277\u20132280.","journal-title":"Diabetes Care"},{"issue":"10","key":"23070830_CR72","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1001\/archpedi.159.10.957","volume":"159","author":"SL Carmicheal","year":"2005","unstructured":"Carmicheal SL, Shaw GM, Laurent C, Croughan MS, Olnet RS, Lammer EJ. Maternal progestin intake and risk of hypospadias. Arch Pediatr Adolesc Med. 2005;159(10):957\u2013962.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"6","key":"23070830_CR73","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1210\/jc.2004-1962","volume":"90","author":"RJ Phillips","year":"2005","unstructured":"Phillips RJ, Tyson-Capper AJ, Bailey J, Robson SC, Europe-Finner GN. Regulation of expression of the chorionic gonadotropin\/luteinizing hormone receptor gene in the human myometrium: Involvement of specificity protein-1 (Sp1), Sp3, Sp4, Sp-like proteins, and histone deacetylases. J Clin Endocrinol Metab. 2005;90(6):3479\u20133490.","journal-title":"J Clin Endocrinol Metab"},{"issue":"16","key":"23070830_CR74","doi-asserted-by":"publisher","first-page":"9518","DOI":"10.1073\/pnas.1633616100","volume":"100","author":"JC Condon","year":"2003","unstructured":"Condon JC, Jeyasuria P, Faust JM, Wilson JW, Mendelson CR. A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition. Proc Natl Acad Sci U S A. 2003;100(16):9518\u20139523.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719115620498.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1933719115620498","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1177\/1933719115620498\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1933719115620498","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719115620498.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T01:46:47Z","timestamp":1656812807000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1177\/1933719115620498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":74,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["23070830"],"URL":"https:\/\/doi.org\/10.1177\/1933719115620498","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"30 December 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}